Twenty-one IncFIV-group plasmids conferring trimethoprim resistance in Escherichia coli isolates from humans and pigs were examined. Three evolutionary lines of plasmids were identified on the basis of restriction enzyme analysis. One was found exclusively in human isolates and another was found in pig isolates, while the third line consisted of plasmids from both sources. All R plasmids readily transferred to laboratory strains, and evidence was found for transfer to 
In a previous study (20) of trimethoprim-resistant isolates from humans and intensively reared pigs, the R plasmids conferring trimethoprim resistance (Tpr) were either 50 to 66 kilobases (kb) in size or greater than 120 kb. The smaller plasmids belonged to the IncN group, while the larger plasmids were incompatible with IncFIV, a relatively rare group (6) . The finding of similar proportions of IncFIV and IncN trimethoprim R plasmids in the bacterial flora of both humans and pigs suggested that there was a common pool of plasmids in the two populations. Recently, Wise et al. (23) also found that there was a common pool of R plasmids with overlapping resistance patterns and incompatibility properties in isolates from humans and animals in central England.
The purpose of this investigation was to characterize further the group of IncFIV trimethoprim R plasmids from human and porcine isolates with the view of demonstrating evolutionary trends. Similar research has been conducted by Tschape and Tietze (22) on R plasmids incompatible with the IncK plasmid R387, by J0rgensen et al. (14) on chloramphenicol-resistant IncFII plasmids, and by Konarska-Kozlowska and Iyer (15) on a group of IncN plasmids. Results of these studies found that many of the restriction enzyme fragments generated were common and that plasmid functions were retained on restriction fragments of the same size. Our results suggest that there has been considerable evolution among the IncFIV plasmids and that a Tpr Escherichia coli has transferred from humans to pigs (or vice versa) and successfully colonized both ecosystems.
MATERIALS AND METHODS
Bacterial strains and plasmids. Standard bacterial strains and plasmids used in this study are described in Table 1 . The human isolates were provided by the Combined Clinical Microbiology Service, Sir Charles Gairdner Hospital, Perth, Western Australia. The porcine isolates were obtained as normal flora fromn the feces ofanimals held at the Government Pig Research Station, located 50 km from the hospital. Strain identification, initial transfer, and incompatibility testing of tritnethoprim R plasmids have been reported previously (20) . Tables 2 and 3 show data on the human and pig IncFIV trimethoprim R plasmids and the strains from which they were isolated.
Resistance (5) .
Cloning of the Tpr gene. Plasmid DNA from representatives of the various sets of trimethoprim R plasmids was digested to completion with EcoRI and ligated to pACYC184 digested with EcoRI. Ligated DNA mixtures were used to transform E. coli JP3438 to Tpr. Transformation of plasmid DNA was done by the method described by Kushner (16) . Tables 2 and 3 are a selection of those recovered from human and porcine isolates during a 15-month survey and are considered to be representative of those circulating at that time. Based on antibiotic resistance patterns and transfer frequencies, the R plasmids were categorized into seven sets. The human plasmids comnprised sets A, B, C, and D; and the porcine plasmids comprised sets D', E, and F. Plasmids with the simplest antibiotic resistance pattern were allocated to set A which included the sulfafurazole and trimethoprim resistance plasmids pHTB1 and pHTB3. The plasmids pHTB19, pHTB20, and pHTB53 were included in set B. Some members of this set conferred very low levels of resistance to tetracycline. For example the MICs for tetracycline conferred by plasmids pHTB19 and pHTB20 were 3.12 and 6.25 ,ug/ml, respectively. Both of these plasmids were recovered from the same isolate. The host to which these plasmids were transferred had an MIC to tetracycline of less than 1 ,ug/ml. The set C plasinids pHTB14, pHTB21, and pHTB23 all conferred resistance to streptomycin, sulfafurazole, tetracycline, and trimethoprim, although pHTB21 exhibited lower levels of resistance to streptomycin and sulfafurazole. Set D comprised the chloramphenicol, sulfafurazole, tetracycline, trimethoprim, and mercuric ion resistance plasmids pHTB8, pHTB9, and pHTB31 and were the only human plasmids which conferred resistance to mercuric ions. All the pig plasmids conferred resistance to mercuric ions. The pig plasmids pPTB34, pPTB151, and pPTB197 were included in set D' because in both size and resistance pattern they resembled the set D plasmids. In addition, the biotypes of the E. coli isolates from which both the set D and set D' plasmids were recovered were identical. The porcine plasmids conferring resistance to sulfafurazole, trimethoprim, and mercuric ions were included in set E; and the sulfafurazole, tetracycline, trimethoprim, and mercuric ion resistance plasmids were included in set F. final digit was derived from the sum of the values for dulcitol and raffinose fermentation, which were given as 1 and 2, respectively; a value of zero was allocated when neither was fermented. The precautions taken to ensure reproducibility have been described previously (20) .
d Transfer frequency is expressed as the ratio of the number of transconjugants to the number of donors after a 4-h broth mating at 37'C. e Plasmid sizes were determined by the summation of EcoRI restriction fragments larger than 0.85 kb.
f See text for explanation of sets. Table 2 for explanation of abbreviations and experimnental details.
b This transconjugant contained a 3-kb cryptic plasmid which was mobilized at a high frequency by the Tpr plasmid.
Restriction enzyme analysis of the plasmid sets. The EcoRI restriction fragment patterns of representatives of the seven plasmid sets are presented in Fig. 1 . The sizes of restriction fragments greater than 0.85 kb are presented in Table 4 and are numbered on the basis of relative size. The fragment patterns were consistent with the sets established on the basis of resistance patterns and size. The set A plasmids differed only in the size of their second largest EcoRI fragments (3 and 4), while all the set B plasmids had identical restriction profiles (only pHTB20 shown). The set C plasmids pHTB21 and pHTB23 had identical restriction fragment profiles, even though pHTB21 exhibited lower levels of resistance to streptomycin and sulfafurazole. Differences found in the other set C plasmid, pHTB14, could be accounted for by the insertion of a 1.37-kb segment of DNA into fragment 34 of pHTB21 or pHTB23 to give one new fragment, 29. Plasmids in sets A, B, and C shared 13 EcoRI fragments among all representatives, with three other fragments (fragments 2, 4, and 34) being common to all but one of the representatives. Plasmids in these three sets were transferred from E. coli of four different biotypes. The set D plasmids pHTB9 and pHTB31 had identical restriction profiles. Plasmid pHTB8 differed from pHTB9, even though it was recovered from the same isolate. It was missing fragments 11, 17, and 22a or b, while additional fragments 19 and 26 were present. Both plasmids pHTB8 and pHTB9, following retransfer to other recipients, retained their restriction fragment patterns. Set D plasmids differed extensively from those of sets A, B, and C, with only three EcoRI fragments being common among all representatives (fragments 12a or b, 22a or b, and 38). The set D' plasmids pPTB34, pPTB151, and pPTB197 all had similar restriction profiles, with 15 EcoRI fragments being common. Differences between these plasmids was confined mainly to the larger EcoRI fragments. These plasmids showed remarkable similarity to the set D plasmids from humans. In particular pPTB34 shared 19 of its 20 EcoRI fragments with pHTB9 and pHTB31. Overall sets D and D' had 14 common fragments, with another four fragments being common to all but one of the representatives (fragments 16, 22a or b, 24 a or b, and 43). All set E plasmids had identical restriction profiles (pPTB64; Fig. 1 ). The set F plasmids were also identical and differed from set E plasmids by the addition of only one fragment (fragment 30) which was presumably associated with the acquisition of tetracycline resistance by this set. In the collection of pig plasmids there was little similarity, with only two EcoRI fragments being common to all representatives (fragments 12a or b and 38). Fragments of this size were found in all 21 Tpr plasmids that were analyzed. All seven E and F set plasmids were transferred from E. coli with different biotypes or antibiograms or both.
Cloning of the Tpr gene. The Tpr genes from representatives of each of the plasmid sets were cloned into the EcoRI site of pACYC184. The EcoRI fragment containing the Tpr gene from each of the sets is indicated in Values are the average of at least three independent determinations. The sizes of fragments greater than 3 kb were determined by using 0.7% agarose with EcoRI fragments Qf lambda as molecular weight standards. Sizes offragments less than 3 kb were determined by using 1 Comparison of Tpr clones by double digestion. The Tpr hybrids were doubly digested with EcoRI and Hindlll, and the fragments generated were analyzed by AGE (Fig. 2A) . Set A, B, and C plasmids showed extensive similarities, as indicated by the number of common fragments, although each set did produce one unique fragment which, in each case, contained the DHFR gene. Set A contained a unique 3.87-kb HindIll fragment, set B contained an 8.72-kb Eco-RI-HindlIl fragment, and set C contained a 3.12-kb HindIlI fragment. The largest HindlIl fragment of set C also appeared to be slightly smaller than the corresponding fragments from sets A and B. Set D produced two EcoRIHindIll fragments (excluding the vector) which were identical to those produced by set D', confirming the close relationship between these sets. Sets E and F were identical with each producing two EcoRI-HindIII fragments (excluding the vector), the smaller of which was identical in size to the largest fragment from sets D and D'. By examination of these clones with restriction enzymes BamHI and PstI (data not shown), it was shown that the regions flanking the Tpr genes in the set D, D', E, and F plasmids were identical and that these regions were different from those regions in sets A, B, and C.
Hybridization of Tpr clones with the type 1 and type 2 DHFR probes. Biotin-labeled probes containing the type 1 and type 2 DHFR genes were hybridized to Southern blots of the double-digested fragments. The results of hybridization with the type 1 probe are presented in Fig. 2B . Hybridization occurred with the control (Fig. 2B, lane 9) and with the smaller of the two vector fragments in lanes 2 through 7 (Fig.  2B) which were produced as a result of EcoRI-HindIII cleavage of pACYC184. This smaller fragment contained the ColEl-related origin of replication of pACYC184. No hybridization occurred with any of the fragments associated with the inserted DNA. The results of hybridization with the type 2 probe are presented in Fig. 2C . Hybridization was observed with the 8.5-kb pSC101 fragment and the 2.4-kb Tn7 fragment (not visible in Fig. 2A ) of the control (Fig. 2C,  lane 8) . Hybridization with the larger of the two vector fragments in lanes 2 through 7 (Fig. 2C) is associated with the tetracycline resistance gene common to pACYC184 and pSC101. No hybridization occurred with the smaller vector fragment or with pFE506 (Fig. 2C, lane 9) , as the pSC101 replicon is distinct from the ColEl replicon. In addition to the vector, the type 2 probe hybridized to a single HindIII or EcoRI-HindIll fragment containing the Tpr gene in each of the lanes 2 through 7 (Fig. 2C) . Thus, all the IncFIV plasmids contained the type 2 DHFR gene which was associated with unique HindIII or EcoRI-HindIII fragments of sets A, B, and C; a common 2.37-kb EcoRI-HindIII fragment in sets D and D'; and a common 5.90-kb EcoRIHindIll fragment in sets E and F.
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In our previous study (20) Studies designed to follow the evolution of R plasmids and to assess their spread, such as that described by J0rgensen (13) , are few. The major difficulty in this type of study is the generally high level of plasmid-borne resistance to the antibiotic under study that is already circulating. Such problems were not encountered in our study. As a result we were able to follow the evolution of trimethoprim R plasmids within the two ecosystems and provide conclusive evidence of the interchange of R plasmid-bearing E. coli between humans and animals.
The plasmids reported here represent the largest single collection of IncFIV plasmids analyzed by restriction enzymes and hybridization, with there having been only four other reports presented previously (4, 8, 12, 17 Plasmid pHTB8 probably represents a deletion derivative of pHTB9 which was selected perchance from that cross. The plasmids in this evolutionary line contained Tpr genes which were part of an EcoRl restriction fragment which appeared to be identical, irrespective of whether they were from human or porcine strains. The remarkable similarity between the plasmids in this line provides clear evidence of recent interchange of R plasmid-bearing E. coli between humans and pigs but conflicting evidence for the direction of plasmid transfer. First, cloning of the Tpr genes from these plasmids revealed that the sequences flanking the DHFR genes were homologous with flanking sequences in the porcine plasmid line. Second, they resembled the porcine plasmids in that they possessed a gene for mercury resistance, a marker not present on any of the human plasmid lines. This indicates that they evolved from the porcine plasmid line and that a clone carrying this plasmid recently entered the hospital environment. However, plasmids of sets D and D' shared more EcoRI restriction fragments with the human plasmids than they did with porcine plasmids. The possession of characteristics of both the human and porcine plasmids cannot be explained easily by a single plasmid exchange event in either direction. On the basis of the shared EcoRI restriction fragments, the D and D' plasmids are more likely to be of human origin. If this is true, then at some stage a human IncFIV plasmid must have transferred to the porcine ecosystem and there acquired resistance to mercury and the porcine-type Tpr gene. This plasmid spread throughout the porcine ecosystem and transferred back into the human ecosystem.
It can be deduced from results obtained with the first two plasmid lines that there was exchange of E. coli between the two ecosystems and conjugal transfer of the R plasmids within each. Plasmids of the third line probably arose as a result of bidirectional exchange of an R plasmid-bearing E. coli between the two ecosystems. It is reasonable to assume that these plasmids are widespread throughout the community because it is unlikely that, from the large range of environments which could have been included in the initial investigation, we selected the only two with nearly identical plasmids. With this in mind, the problems associated with deciding from which environment the resistance arose become less important, considering the ease and frequency with which the R plasmids are exchanged. Policies on antibiotic use therefore should consider not only the proposed use in either clinical or veterinary practice but also the capacity of the agent to select for R plasmid-mediated resistance.
